Regulation of cell cycle checkpoints by polo-like kinases

被引:93
作者
Xie, SQ
Xie, B
Lee, MY
Dai, W [1 ]
机构
[1] New York Med Coll, Dept Med, Mol Carcinogenesis Div, Valhalla, NY 10595 USA
[2] New York Med Coll, Brander Canc Res Inst, Valhalla, NY 10595 USA
[3] New York Med Coll, Dept Biochem, Mol Carcinogenesis Div, Valhalla, NY 10595 USA
关键词
polo; polo-like kinases; cell cycle; checkpoint; cell division;
D O I
10.1038/sj.onc.1208218
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Protein kinases play a pivotal role in execution of cell division. Polo and Polo-like kinases have emerged as major regulators for various cell cycle checkpoints. Early genetic studies have demonstrated that CDC5, a budding yeast counterpart of vertebrate Plks, is essential for successful mitotic progression. Mammalian Plks localize primarily to the centrosome during interphase and the mitotic apparatus during mitosis. Many key cell cycle regulators such as p53, Cdc25C, cyclin B, components of the anaphase-promoting complex, and mitotic motor proteins are directly targeted by Plks. Although the exact mechanism of action of these protein kinases in vivo remains to be elucidated, Plks are important mediators for various cell cycle checkpoints that monitor centrosome duplication, DNA replication, formation of bipolar mitotic spindle, segregation of chromosomes, and mitotic exit, thus protecting cells against genetic instability during cell division.
引用
收藏
页码:277 / 286
页数:10
相关论文
共 50 条
[31]   Polo-like kinase 1 inhibition causes decreased proliferation by cell cycle arrest, leading to cell death in glioblastoma [J].
J A Pezuk ;
M S Brassesco ;
A G Morales ;
J C de Oliveira ;
R G de Paula Queiroz ;
H R Machado ;
C G Carlotti ;
L Neder ;
C A Scrideli ;
L G Tone .
Cancer Gene Therapy, 2013, 20 :499-506
[32]   Regulation of yeast forkhead transcription factors and FoxM1 by cyclin-dependent and polo-like kinases [J].
Murakami, Hiroshi ;
Aiba, Hirofumi ;
Nakanishi, Makoto ;
Murakami-Tonami, Yuko .
CELL CYCLE, 2010, 9 (16) :3233-3242
[33]   Analyses of expressions and prognostic values of Polo-like kinases in non-small cell lung cancer [J].
Yu Zeng ;
Nanhong Li ;
Wang Liu ;
Mingqing Zeng ;
Junfen Cheng ;
Jian Huang .
Journal of Cancer Research and Clinical Oncology, 2020, 146 :2447-2460
[34]   Analyses of expressions and prognostic values of Polo-like kinases in non-small cell lung cancer [J].
Zeng, Yu ;
Li, Nanhong ;
Liu, Wang ;
Zeng, Mingqing ;
Cheng, Junfen ;
Huang, Jian .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2020, 146 (10) :2447-2460
[35]   Polo-like kinases and DNA damage checkpoint: beyond the traditional mitotic functions [J].
Bahassi, El Mustapha .
EXPERIMENTAL BIOLOGY AND MEDICINE, 2011, 236 (06) :648-657
[36]   Polo-like kinases as potential targets and PLK2 as a novel biomarker for the prognosis of human glioblastoma [J].
Ding, Yiming ;
Liu, Hanjie ;
Zhang, Chuanbao ;
Bao, Zhaoshi ;
Yu, Shuqing .
AGING-US, 2022, 14 (05) :2320-2334
[37]   Inhibition of Polo-like Kinase 1 by HMN-214 Blocks Cell Cycle Progression and Inhibits Neuroblastoma Growth [J].
Chilamakuri, Rameswari ;
Rouse, Danielle Crystal ;
Agarwal, Saurabh .
PHARMACEUTICALS, 2022, 15 (05)
[38]   Polo-like kinase 3 is Golgi localized and involved in regulating Golgi fragmentation during the cell cycle [J].
Ruan, Q ;
Wang, Q ;
Me, SQ ;
Fang, YQ ;
Darzynkiewicz, Z ;
Guan, KL ;
Jhanwar-Uniyal, M ;
Dai, W .
EXPERIMENTAL CELL RESEARCH, 2004, 294 (01) :51-59
[39]   A Pan-Specific Inhibitor of the Polo-Box Domains of Polo-like Kinases Arrests Cancer Cells in Mitosis [J].
Reindl, Wolfgang ;
Yuan, Juping ;
Kraemer, Andrea ;
Strebhardt, Klaus ;
Berg, Thorsten .
CHEMBIOCHEM, 2009, 10 (07) :1145-1148
[40]   Overexpression of oncogenic polo-like kinase 1 disrupts the invasiveness, cell cycle, and apoptosis in synovial sarcoma [J].
Zhang, Jun ;
Li, Zhong ;
Xie, Ming-Yu ;
Wang, Ning ;
Liu, Hao ;
Li, Feng ;
Pang, Li-Juan ;
Qi, Yan .
JOURNAL OF TRANSLATIONAL MEDICINE, 2025, 23 (01)